NF2 and Vestibular schwannoma: Christine Dinh, MD, developed a translational research pipeline for testing novel therapies in vestibular schwannoma and neurofibromatosis 2 (NF2), led the multidisciplinary team that established the University of Miami Auditory Brainstem Implant Program (10), and is the site investigator of the INTUITT-NF2 Trial (11).